Artiva Biotherapeutics logo

Artiva Biotherapeutics

ARTV | NASDAQ
Chart Builder DCF Calculator
$3.96
-$0.05 (-1.25%)
At close: Nov 16, 2026, 4:00 PM ET
$3.94
-$0.02 (-0.51%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.25%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
20.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #985/1021 (Top 96%)

Key Statistics

Market Data

Market Cap $195.75M
1D Range
3.93 4.06
52W Range
3.07 13.39

Valuation (TTM)

PE -1.32
PB 0.61
EV/EBITDA 1.20

Valuation (NTM)

Forward PE N/A
Forward PEG 0.07
Price Target $4.00
Loading financial charts...

Profile

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology firm specializing in the development of natural killer (NK) cell-based treatments for individuals afflicted with autoimmune disorders and...

Sector Healthcare
Industry Biotechnology
Employees 115
IPO Date Jul 19, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
5
Consensus
Hold
Price Target
$4.00
Upside
+1.01%
Buy (2)
Hold (3)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.